Trametinib for Painful Glomus Tumors in a Patient with Neurofibromatosis Type 1

Seth A Climans^#^{1

2}, Ronald C Ramos^#^{1

3}, Dimitri J Anastakis⁴, Warren P Mason¹

Affiliations

¹ Departments of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
² Department of Oncology, London Health Sciences Centre, London, Canada.
³ Division of Neurology, Hamilton Health Sciences, Hamilton, Canada.
⁴ Division of Plastic and Reconstructive Surgery, Department of Surgery, Toronto Western Hospital, Toronto, Canada.

^# Contributed equally.

Seth A Climans et al. Can J Neurol Sci. 2023 May.

. 2023 May;50(3):477-478.

doi: 10.1017/cjn.2022.36. Epub 2022 Mar 31.

Seth A Climans^#^{1

2}, Ronald C Ramos^#^{1

3}, Dimitri J Anastakis⁴, Warren P Mason¹

¹ Departments of Neurology and Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
² Department of Oncology, London Health Sciences Centre, London, Canada.
³ Division of Neurology, Hamilton Health Sciences, Hamilton, Canada.
⁴ Division of Plastic and Reconstructive Surgery, Department of Surgery, Toronto Western Hospital, Toronto, Canada.

^# Contributed equally.

No abstract available

Keywords: Glomangioma; Neuro-oncology; Neurofibromatosis type 1; Plastic surgery; Targeted chemotherapy.

Publication types